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Abstract
Background: Arachnomelia syndrome is an autosomal recessive inherited disease in cattle. Affected calves die
around birth and show malformations of the skeleton mainly affecting the legs, the spinal column and the skull.
A number of arachnomelia syndrome affected Simmental calves were recently detected by a surveillance system of
anomalies with a peak of more than 120 recorded cases in the year 2006. The causative mutation was previously
mapped to a 9 cM-region on bovine chromosome 23. We herein report the fine-mapping and identification of the
gene causing arachnomelia syndrome in Simmental cattle.
Results: By using a dense set of markers, the arachnomelia syndrome linked region could be refined to 1.5 cM
harbouring three protein coding genes. Comparative sequencing of these genes revealed a two-bp-deletion in the
bovine MOCS1 gene resulting in a frame-shift and a premature termination codon. We genotyped affected calves
and their ancestors and found that all affected were homozygous for the deletion whereas all carriers were
heterozygous. Furthermore, cattle from the same population, but not directly related to known carriers mostly
showed the wild type genotype.
Conclusions: MOCS1 encodes two proteins that are involved in the first synthesis step of molybdenum cofactor. A
non functional sulfite-oxydase, one of the enzymes requiring molybdenum cofactor, leads to a similar pathology in
Brown Swiss cattle. In combination the perfect association of the mutation with the phenotype and the obvious
disruption of protein translation provide strong evidence for the causality of the MOCS1 mutation. Our results are
the first example for an oligogenic lethal inherited disease in cattle. Furthermore, they show the potential
involvement of sulfite metabolism in aberrant bone development.
Background
The congenital arachnomelia syndrome (AS, OMIA
Phene ID 139, Group 000059) in Holstein Friesian, Red
Holstein and Simmental cattle was initially described by
Rieck and Schade [1]. The cardinal pathological changes
are skeletal malformations of the skull, legs and the
spinal column [2]. The facial deformation leads to bra-
chygnathia inferior and concave rounding of the maxilla
forming a dent (’pointer-head’). The legs show abnor-
mally thin diaphyses of the long bones and stiffened,
hyperextended fetlocks (’spider-legs’, dolichostenomelia),
leading to frequent fractures of the metacarpus and
metatarsus in the course of forced birth assistance. The
vertebral formation failure results in kyphosis and
scoliosis.
In the 1980s, the syndrome was dispersed in European
Brown Swiss cattle by the use of American Brown Swiss
sires [3] and in 2005 AS reappeared in Simmental.
There were more than 150 confirmed cases in this
breed with a peak in 2006 [2]. It could be shown by
pedigree analysis that AS is most probably a monogenic
recessive inherited disease with an estimated allele fre-
quency of 3% in the current cow population [2]. Subse-
quently, AS was mapped to a 9 cM-region on bovine
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89 affected Simmental calves [4]. An indirect gene test
was developed and applied to several hundred sires that
had a pedigree-based risk to be a carrier of AS (results
are publicly available [5]). The availability of the indirect
genetic test and the awareness of the disease by the arti-
ficial insemination centres and breeders led to a sharp
decline in cases after 2007 [4]. AS is the first oligogenic
Mendelian inherited disease found in cattle, since it was
mapped to a different location (on bovine chromosome 5)
in Brown Swiss [6].
In this study, we present the fine mapping and
identification of the putative disease causing mutation of
AS in Simmental cattle thereby providing insights into
the genetic basis of AS and the biology of bone
development.
Results
Fine mapping of the AS region
In a previous work we mapped the AS-condition in
Simmental cattle to a ~9 cM-region. The corresponding
region was covered with additional markers to further
narrow down the AS locus. Published [7] as well as
newly developed microsatellites were tested within the
AS families. Finally, 11 informative additional microsa-
tellites were chosen and the AS families were genotyped
(Table 1, Additional file 1). The 86 cases available for
fine mapping came from 4 half sib families. Therefore,
the paternal and, subsequently, the maternal haplotype
could unambiguously be deduced in most cases. 17-mar-
ker haplotypes were constructed for all genotyped cases.
We analysed the minimal region without recombination
and the region with complete homozygosity within the
AS-affected animals. Both analyses led to the identical
minimal candidate region of AS between the markers
RM033 and LFL014 (Figure 1, Table 2). This region is
about 0.7 cM or 1.5 Mb in length. These results
excluded some prominent candidate genes that are
located close to the region in question: RUNX2 and
CUL7 that had been associated with diseases of the ske-
leton [8,9].
Investigating candidate genes within the region carrying
the AS mutation
The 1.5 Mb-core candidate region on chromosome 23
harboured one pseudogene, a TAF9 RNA polymerase II,
one UAU-encoding tRNA gene, and three protein-
coding genes, DAAM2, MOCS1,a n dLRFN2,t h a tw e r e
annotated in BTAU4.0 (Figure 1). Based on their func-
tional annotation none of these genes was a straightfor-
ward candidate with a known function in bone or
cartilage development. The pseudogene is similar to
TAF2G encoding an ubiquitously expressed transcrip-
tion factor that is essential for cell viability [10].
DAAM2 encodes the dishevelled associated activator of
morphogenesis 2 that is involved in the wnt signalling
pathway [11] implying a role in early cell development.
Nevertheless, the gene function is not very well under-
stood and there are no data from disease associations or
animal models. MOCS1 encodes the molybdenum cofac-
tor synthesis 1 protein that is involved in the synthesis
of the molybdenum cofactor (Moco). Moco is required
by at least three enzymes, sulfite-oxidase, xanthine-dehy-
drogenase, and aldehyde-oxidase. Known mutations
Table 1 Microsatellites used for fine mapping of the arachnomelia syndrome locus
Marker name* cM
† App. location (kb)
‡ Fragment length range (bp) Reference Remarks
BM47 13.8 7,765 222-268 This publication; [7]
DIK4340 16.2 10,153 192-204 [7]
DIK4895 17,9 11,332 174-192 [7]
BM3401 18.8 11,455 124-146 This publication; [7]
LFL023 - 11,619 126-194 This publication
LFL024 - 12,108 172-194 This publication
DIK5399 20.7 13,273 193-201 [7]
LFL018 - 13,670 215-241 This publication located within KCNK17
RM033 20.7 13,796 146-156 [7]
LfL015 - 14,354 130-152 This publication located between DAAM2 and MOCS1
LFL016 - 14,751 131-187 This publication
NRKM17 21.3 15,050 129-141 [7]
LFL014 - 15,281 110-134 This publication
LFL012 - 16,190 118-163 This publication triple repeat
LFL006 - 17,329 121-201 This publication located close to PTK7
BM1258 28.3 19,935 92-106 [7]
DIK4396 39.9 24,934 156-173 [7]
*Italicized names represent markers that had been used for whole genome linkage analysis [4];
†genetic distance according to [7];
‡according to BTAU4.0.
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Page 2 of 10within MOCS1 lead to an autosomal recessive disease,
the molybdenum cofactor deficiency, with neurological
symptoms in humans [12]. The last gene, LRFN2 encod-
ing the leucine-rich repeat and fibronectin type III
domain-containing protein 2, is known to interact with
different receptors in brain tissue and plays a role in t-
cell development and hematopoiesis [13]. Nevertheless,
the protein seems to interact with the NMDA receptors
[14] that, among other functions, are involved in bone
development [15,16]. Since there was no convincing
candidate, we systematically sequenced the exonic and
part of the intergenic, 5’ and 3’ regions of all three
genes. The genomic organization of the bovine DAAM2
and MOCS1 was derived from the BTAU4.0 annotation,
whereas the exons of LRFN2 were deduced from human
and mouse EST and RNA data, since the first exon was
not annotated. In total 22.4 kb were sequenced and
twelve mutations, including one deletion, were detected
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Figure 1 Partial genetic map of BTA23 and genes located within the arachnomelia syndrome region. The genetic map of the proximal
region of BTA23 is shown at the left side. The region containing the arachnomelia syndrome condition is indicated by a gray rectangle. This
region is enlarged in the middle. On the right the location and distribution of exons of annotated genes within the region is shown.
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Page 3 of 10Table 2 Haplotypes of arachnomelia syndrome-affected animals of 17 microsatellites of chromosome 23
Marker arachnomelia syndrome associated haplotypes
Name* Chr 23
(Mb)
†
123456789 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 1 9 2 0 2 1 2 2 2 3 2 4 2 5 2 6 2 7 2 8 2 9 3 0 3 1
BM47 7.77 232 222 238 238 240 238 254 254 234 268 238 254 268 220 254 238 238 254 232 232 234 240 238 238 254 232 222 238 238 238 234
DIK4340 10.16 198 198 204 204 204 204 198 198 198 198 200 198 202 198 198 204 204 198 204 198 200 204 204 198 192 198 204 204 204 204 204
DIK4895 11.33 188 192 192 192 192 190 190 190 190 192 190 174 190 190 192 192 190 192 174 192 192 192 190 190 174 192 192 192 192 192
BM3401 11.46 126 128 140 140 140 140 126 126 126 126 140 126 128 126 126 140 140 126 140 128 140 140 140 126 140 128 140 140 140 140
LFL023 11.62 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126
LFL024 12.11 188 178 190 190 190 190 178 178 178 178 190 178 178 178 178 190 190 178 190 184 190 190 190 178 188 184 190 178 190 190
DIK5399 13.27 197 197 197 197 197 197 197 197 197 197 197 197 197 197 197 197 197 197 199 197 197 197 197 197 199 197 197 197 197
LFL018 13.67 225 227 227 227 227 227 227 227 227 227 227 227 227 227 227 227 227 227 227 227 227 227 227 227 225 227 227 227 227 227 227
RM033 13.80 148 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150
LFL015 14.35 144 144 144 144 144 144 144 144 144 144 144 144 144 144 144 144 144 144 144 144 144 144 144 144 144 144 144 144 144 144 144
LFL016 14.76 133 133 133 133 133 133 133 133 133 133 133 133 133 133 133 133 133 133 133 133 133 133 133 133 133 133 133 133 133 133 133
NRKM17 15.05 135 135 135 135 135 135 135 135 135 135 135 135 135 135 135 135 135 135 135 135 135 135 135 135 135 135 135 135 135 135 135
LFL014 15.28 130 130 130 130 130 130 130 130 130 130 130 130 130 130 130 130 130 130 130 112 130 130 130 130 130 130 130 130 130 130
LFL012 16.19 160 160 163 163 163 163 160 160 160 160 160 160 160 160 145 163 163 160 142 157 145 163 160 160 160 160 163 163 163 163 163
LFL006 17.33 193 193 193 193 193 193 193 195 193 193 193 193 193 193 193 193 193 193 197 193 191 193 193 193 193 193 193 193 193 173 173
BM1258 19.94 96 96 98 98 98 98 96 98 96 96 96 96 96 96 96 102 98 96 100 96 102 98 98 98 96 98 98 98 98 102 102
DIK4396 24.94 162 165 167 167 162 162 165 162 162 165 165 162 162 150 167 173 167 162 162 164 162 165 162 167 165 165 165 167 167
The minimal genetic region is shown in bold; *Italicized names represent markers that had been used for whole genome linkage analysis [4]; †according to BTAU4.0.
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0within the three genes by comparative sequencing of
one unrelated, one AS-carrier, and two AS-affected ani-
mals (Table 3).
A panel of additional animals was tested for these
alleles either by direct sequencing, allele-specific PCR or
PCR-RFLP assays. Excluding (either an AS-affected calf
being not homozygote or a known carrier being not het-
erozygous for the mutation and the wt allele) genotypes
were found for all mutations, except for the deletion
within MOCS1.
Mutation of the bovine MOCS1 gene
The two bp-CA-deletion (Figure 2) is located at RNA
(GI:261490660) position 1224-1225 (numbering starting
at the A of the translation start codon) that is located in
exon 11 of MOCS1 (c.1224-1225delCA). A genotyping
system based on allele specific PCR was designed for the
mutation and all cases as well as the family members
available were genotyped (Table 4). As expected, all
affected calves were homozygote for the mutation (del/
del), whereas all parents were heterozygote (wt/del). As
a control, cattle sampled randomly from the Bavarian
Simmental population excluding first-degree relatives of
known carriers were genotyped. None of them was
homozygote for the c.1224-1225delCA mutation, but
about 2.8% were heterozygote. The mutation was not
observed in 120 cattle from other breeds (German Gelb-
vieh, Holstein Friesian, Belgian Blue and Braunvieh). We
analysed the pedigrees of the heterozygous Simmental
cattle from the random sample and found that, as pre-
viously observed for the affected calves, all could be
traced back to SEMPER or his sire SENAT, confirming
the hypothesis, that SENAT may be the founder and
that most of the carriers inherited the mutation via
SEMPER [2].
Finally, 67 sires that were known to be putative car-
riers of the mutation, either by pedigree analysis or by
results from genetic testing [5], were genotyped. These
sires include ROMEL and REXON, that produced a
large number of daughters. All 67 sires were heterozy-
gous for the deletion. DNA from the suspected founder,
SEMPER, was not available, but DNA from one of his
sons (SENDER) and brothers (SET) were genotyped.
These were homozygous for the wild type allele. This
result is in agreement with the finding, that all pedigrees
available can be traced back to SEMPER via one of his
daughters, but not to one of his sons. Two affected
calves, that were considered as phenocopies since there
was no connection of their pedigrees with SEMPER or
SENAT [2, Table 4] were homozygote for the wild type
allele.
MOCS1 is one of the rare genes known to express a
polycistronic RNA. It produces two different enzymes
(MOCS1A and MOCS1B) from non-overlapping open-
reading-frames from a bicistronic transcript [12]. The
RNA is known to occur in different splice types in ver-
tebrates including mouse, human, cattle and inverte-
brates [17]. At least two splice types seem to exist in
cattle, encoding either MOCS1A or a functional
MOCS1B that is translated as a fusion with an inactive
MOCS1A protein (Figure 3).
The reference sequence (GI:261490661) of the bovine
MOCS1 is 633 amino acids in length and the C-
terminus encoding the Moa-C domain is highly con-
served within mammals (Figure 4). The 2 bp deletion
leads to a predicted frame shift beginning at amino acid
position 24 of MOCS1B. The altered protein is 73
amino acids in length and the complete MoaC domain
is skipped. Therefore, the altered protein is unlikely to
be functional.
Table 3 Results from the comparative sequencing of the three positional candidate genes of affected and unaffected
cattle
Name N exons kb sequenced N mutations position and type of mutations
DAAM2 24 13.91 2 c.2017c > g synonymous exon 16
c.2145 + 22c > t - intron 16
MOCS1 11 4.63 2 c.711t > c synonymous exon 6
c.1224- frameshift exon 7
1225delCA
LRNF2 3 3.86 8 c.-72a > g - intron 1
c.-87a > g - intron 1
c.-116a > g - intron 1
c.216t > c synonymous exon 2
c.525a > g synonymous exon 2
c.622a > c synonymous exon 2
c.927g > a synonymous exon 2
c.1095t > c synonymous exon 2
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The emergence of the bovine AS caused serious concern
among European Simmental breeders in 2006, since the
disease was transmitted by some top sires that had been
extensively used. Therefore, we mapped the AS locus
and an indirect gene test was made available in summer
2007 that was an effective tool to control the disease by
genotyping sires with conspicuous pedigrees.
To explore the disease mechanism and to avoid the
drawbacks of an indirect gene test, the causative muta-
tion should be identified based on the initial mapping
data. Additional regional markers were applied and the
AS region was finally narrowed down to a 1.5 Mb-
region containing five genes. Since none of them could
convincingly be associated with the phenotype of AS,
three genes were comparatively sequenced. As a result,
exactly one obviously functional mutation in MOCS1
could be identified. Genotyping of a large panel of
affected, obligate carrier and unrelated cattle provided
additional evidence, that we identified the genuine AS
mutation for Simmental cattle.
MOCS1 encodes a bicistronic RNA that is translated
into MOCS1A and MOCS1B that are involved in the
first step of the synthesis of Moco. They are analogous
to the MoaC and MoaA enzymes of Escherichia coli and
promote the synthesis of precursor Z (or cyclic pyranop-
terin monophosphate, cPMP) from a 5’-GTP derivate.
Mutations of MOCS1 that lead to an inability of synthe-
sising functional precursor Z cause Moco-deficiency
type A (MIM 252150) in human, an autosomal recessive
inherited disease that is mainly characterised by neuro-
logical symptoms due to brain dysmorphisms (loss of
white matter in the CNS) [18]. Nevertheless, mutations
of an other gene leading to a disturbed sulphur metabo-
lism, CBX, cause homocystinuria that is associated with
wildtype(wt/wt)
carrier (wt/del)
affected (del/del) affected (del/del)
Figure 2 Sequence tracks encompassing the arachnomelia syndrome-causing mutation within the bovine MOCS1. Selected sequence
tracks enclosing the c.1224-1225delCA mutation. From top to bottom electropherograms of a wild type (wt/wt), a carrier (wt/del), and an
arachnomelia affected calf (del/del) are shown. The CA dinucleotide at postion 192-193 (indicated by the yellow box) of the wild type sequence
is deleted in the sequence of the affected calf.
Table 4 Genotype frequencies of the MOCS1 deletion
wt/wt wt/del del/del
Affected calves
† 0 0 154
Carriers 2* 219 0
Unrelated Simmental cattle 599 17 0
Cattle from four other breeds 241 0 0
Total 843 236 154
†The parents of arachnomelia syndrome-affected calves. *The arachnomelia
syndrome signs of the affected calves that are descendents from these two
sires are considered to be phenocopies [2].
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Page 6 of 10different signs including abnormally developed pha-
langes (arachnodactyly) [19].
Homozygous MOCS1 knock-out mice show curly
whiskers, die between day 1 and 11 of age and are smal-
ler than wt mice, but do not show any other morpholo-
gical abnormalities or significant changes in CNS [20].
MOCS1
-/- mice show the biochemical characteristics of
sulfite and xanthine intoxication, e.g. elevated sulfite and
xanthine levels and undetectable levels of uric acid in
the urine. The main pathological mechanism seems to
be mediated by the sulfite oxidase deficiency (SOD),
since, probably due to redundancy, known isolated defi-
ciencies of other molybdenum dependent enzymes
(aldehyde oxidase and xandthine oxidoreductase) do not
result in clinical symptoms in humans [21,22]. The pre-
cise mechanisms of this toxicity are not completely
understood. In mice, cell death appears to be triggered
by elevated sulfite levels [23].
All splice forms of MOCS1 a r ef o u n di nac o n s t a n t
ratio in a wide range of tissues, probably reflecting its
universal use [24]. In cattle the main predilection site of
Moco-deficiency is the developing bone. Even though
bone malformations are not common signs of Moco-
deficiency in human and mice, rarely microcephaly and
a prominent forehead are observed in patients with
Moco- [25] and SOD-deficiency [26].
Mice and children with Moco-deficiency are usually
born alive. It was postulated that sulfite is ameliorated
in affected embryos by maternal clearance and there-
fore damage seems to be modulated till birth [23].
Most probably this is not the case in cattle due to the
non-invasive implantation. Therefore, (bone-)tissue is
not protected from damage from elevated sulfite
levels.
Finally, the causative role of MOCS1 in bovine AS is
strongly supported by the recent discovery of a SUOX
mutation leading to a similar phenotype in Brown Swiss
cattle [27]. Therefore, AS is the first known example for
an oligogenic inherited disease in cattle caused by muta-
tions within genes of an enzyme and its cofactor. These
results provide impetus for investigating the possible
role of elevated sulfite levels in aberrant bone
development.
Moco can be treated by purified precursor Z in mouse
[23]. In cattle it will not be possible to treat Moco in
near future, since the critical insult occurs during fetal
development and affected calves usually are not viable
postnatally. Instead, AS is controlled by excluding car-
riers of the mutation from breeding. Replacing the indir-
ect by a direct gene test will accelerate the eradication
of AS from the Simmental population. Since the direct
gene test is not only more efficient but also easier and
cheaper than the indirect gene test, it will become feasi-
ble to test larger numbers of breeding cows. This is
important due to the comparatively high frequency of
carriers in the current cow population.
Conclusions
Our results strongly support the hypothesis that a miss-
ing molybdenum cofactor, leading to non functional
Moco-dependent enzymes, namely sulfite oxidase, lead
to aberrant bone development in bovine AS.
There are 4 lines of evidence for the mutation of
MOCS1 being causative for AS. 1) AS is an autosomal
recessive inherited lethal disease. Therefore, it could be
expected that a loss of function mutation is the cause of
AS. 2) The genotyping results of additional animals
show complete concordance of the deletion genotype
with the AS phenotype. 3) Mutations of MOCS1 or the
dependant SUOX can also lead to bone malformations
in human. 4) The corresponding mutation of SUOX
leads to a similar phenotype in Brown Swiss cattle.
Splice Type I 
 
...ʊʊʊʊʊʊʊʊʊʊʊʊ Exon 10 ʊʊʊʊʊʊ><ʊʊʊ Intron 10 ʊʊʊʊʊʊ><ʊʊʊʊʊʊ Exon 11 ʊʊʊʊʊʊʊ...
...ATGATCCTCATCGGTGGGTGACCCATCAgtacgtaa..//..cattctagAGTTATTTTTGATGCGCCAAGAT...
 .  M  I  L  I  G  G  *  P  I                        K  L  F  L  M  R  Q  D  . 
 
 
Splice Type II 
               ...ʊʊ Exon 10 ʊ><ʊʊʊ Intron 10 ʊʊʊʊʊʊ><ʊʊʊʊʊʊ Exon 11 ʊʊʊʊʊʊʊ...
               ...ATGATCCTCATCGgtgggtga..//..cattctagAGTTATTTTTGATGCGCCAAGAT...
                .  M  I  L  I                        E  L  F  L  M  R  Q  D  . 
Figure 3 Alternative splicing of the bovine MOCS1. Part of the genomic sequence and the deduced amino acids of exon 10, intron 10 and
exon 11 of the bovine MOCS1 is shown. Exon-intron boundaries are indicated by arrows above the nucleotide sequence. The coding sequences
of the predicted RNAs are shown with capital letters, intronic sequence with small letters indicating the putative splice sites leading to splice
type I and II. Splice type II leads no the no-nonsense transcript (predicted RNA accession number GI:261490660) that is translated into a
functional MOCS1B protein. The end of MOCS1A (top) and the beginning of MOCS1B protein sequences (bottom) are shown in bold.
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ASMT   ............-...........QSEFLQPDGDFMERRR.P.GPSCCPAVAGVQPPSETLQFPPGLRCQPKVP*      
RANO   .L......SW..LSWDP.H.RNPGAKQCL.D..A....RHS..M.LPLS.QC...GS....Y..YP.P.TH.-....T-G 
MUMU   .L......RW.NFSWDP...RNPSA.QCL.D..AS...RHCI.K.LPLS.QC...GS....Y..YP.P.THS-....T-G 
CAFA   .L......I..ISSQDPFH..GI.......NR.S.W...CW.SRT.PLG...SN.--....C..........-....A-V 
PATR   .FHN....N..IFSWDP.HF.G..P.M.....VA.....CR...T.PL..QR...GFF...YT.RA.L...S-.....-G 
HOSA   .FPN....N..IFSWDP.H..G..P.M.....VA.....CR...T.PL..QR...GSF...YT.RA.....S-.....-G 
AIME   .L......I..ISSQDPF.I.GI.......N..A......W.L.T.VL..WR...GC....C......N..T-....A-V 
SUSC   .L......I..ISL.G.....G......S..........CW......L.......GF....L...P......K.....-. 
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                                                               ˪ʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊʊ 
                                                                      #               # 
BTAU   PQAPAASSGPLPDSDQLTHVDTEGRMAMVDVGRKPDTERVAVASAVVLLGPVAFKLIQENQLKKGDALAVAQLAGIQAAK 
RANO   SR..DVP...G.T........SA..AT.....G..E.........M.....K....V.Q.........V......V.... 
MUMU   S...D.P...G.T.N......SA..AS.....G..E.........M..........V.Q.........V......V.... 
CAFA   SG...TP.....T............A......G.......................V...........V......V.... 
PATR   SW.S..P...QLT.E......A...A..............................V.Q.........V......V.... 
HOSA   SW.S..P...QLT.E......S...A..............................V.Q.........V......V.... 
AIME   S....TP.....P..H.........A............................R.VR..........VI.....V.... 
SUSC   .R...TP.....T............A..............................V...........V........... 
 
               170       180       190       200       210       220       230       240
       ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
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BTAU   LTSQLIPLCHHVALSHVQVQLELDRTRHAAVIQASCRARGPTGVEMEALTSAAVAALALYDMCKAVSRDIVLAEIKLVSK 
RANO   ...................H....S....VL..V...................M...TV............VT.V..I.. 
MUMU   ...................H....S....VL......................M...TV............VT.V..I.. 
CAFA   ...................R....GA...VG.R.....W...........A......T..............G....L.. 
PATR   V...............I.......S....VK..........................T..............E....I.. 
HOSA   V...............I.......S....VK..........................T..............E....I.. 
AIME   .................H......S....VG...................A......TV.....G.......G....L.. 
SUSC   ...................W....S....V...........................T..............G....D.. 
 
               250  
       ....|....|. 
       ʊʊʊʊʊʊʊ˫ 
BTAU   TGGQRGDFHRT  
RANO   ...........  
MUMU   ..........A  
CAFA   ...........  
PATR   ..........A  
HOSA   ..........A  
AIME   ........Q.-  
SUSC   ........Q..  
Figure 4 Comparison of deduced MOCS1B amino acid sequences among cattle, rat, mouse, dog, chimpanzee, human, giant panda
and pig and the mutated protein causing the bovine arachnomelia syndrome. Sequences were derived from GenBank (BTAU, Bos taurus,
gi 261490661; RANO, Rattus norvegicus, gi 149069513; MUMU, Mus musculus, gi 161484628; CAFA, Canis familiaris, gi 73972793; PATR, Pan troglodytes,
gi 114607308; HOSA, Homo sapiens, gi 30913216; AIME, Ailuropoda melanoleuca, gi 281353482; SUSC, Sus scrofa, gi 19403921). The second line
shows the predicted MOCS1B amino acid sequence of calves carrying the arachnomelia syndrome mutation (ASMT) The line above the
sequence alignment indicates the MoaC-domain and number signs indicate the highly conserved amino acid residues that are thought to be
involved in the biosynthesis of precursor Z [31].
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Collection and DNA extraction
The collection of AS-affected Simmental calves had
been described previously [4]. In short, affected calves
were identified in the course of the Bavarian surveillance
programme for inherited congenital malformations.
Only calves with AS status confirmed by pathological
investigation were included in the study. DNA from tis-
sue was prepared using the DNA tissue kit (Qiagen).
DNA from blood was prepared using a blood kit (PEQ-
LAB Biotechnology GmbH). Pedigrees were extracted
from the joint German and Austrian Simmental pedi-
gree data used for routine genetic evaluation.
For determination of allele frequencies Simmental cat-
tle were collected from the performance testing station
reflecting the breeding population of the years 2002 -
2008 when the AS mutation was spread in the popula-
tion by some prominent sires [2]. Cattle with parents
being known carriers were excluded from the analyses.
Holstein Friesian and Braunvieh cattle were male calves
bought from local breeders in Bavaria.
Microsatellite genotyping
DNA from pedigree members were genotyped with 17
microsatellites covering the region 13-40 cM on chro-
mosome 23 (Table 1, Additional File 1). These were
selected from the map published by Ihara [7] or devel-
oped based on the bovine RefSeq assembly BTAU4.0
(Table 1). One primer of each pair was fluorescently
labelled and microsatellites were amplified in 10 μl-
reactions and separated on an ABI Prism 310 Genetic
Analyzer (Applied Biosystems) as described [4]. Frag-
ment sizes were measured and allele tables were gener-
ated using the GENEMAPPER (V. 3.0, Applied
Biosystems) software.
Comparative sequencing
Exonic as well as part of the intergenic, 5’-a n d3 ’-
regions of three genes were amplified in 10 μl reac-
tion volume using 2 μl of genomic DNA, 0.05 μMo f
each primer (Supplement 1), 50 μM of each dNTP,
0.5 units of HotStar-taq polymerase (Qiagen, Hilden,
Germany), and reaction buffer containing 1.5 mM
MgCl2. Cycling-conditions on a Biometra T gradient
96-well thermocycler were: 15 min at 95°C, [0.5 min
at 95°C, 1 min at 60°C, 0.5 min at 72°C]35 × and 10
min, 60°C final extension. Before direct sequencing
PCR-reactions were purified using the QIAquick PCR
Purification Kit. Sequencing was performed using Big-
Dye V 3.0 terminator cycle sequencing kit (Applied
Biosystems, Foster City, CA). Sequencing analysis was
r u no na nA B IP R I S M
® 310 genetic analyser. Single
nucleotide variation was analysed using PolyPhred
[28-30].
Allele specific PCR genotyping system
Primers (5’-cctgacatgaacaggggaac-3’,5 ’- ccaggtgggaact-
gaagtgt-3’,5 ’-tggagaaactcactctgtgtctc-3’,5 ’- gtgttcaggttct-
gagacagagt-3’) were designed in order to amplify the
two alleles of the 2-bp deletion in an tetra-ARMS reac-
tion. 1.5 pmol of each primer were used to amplify 30
ng genomic DNA in a 10 μl PCR reaction with 0.5 units
of HotStar-taq polymerase (Qiagen, Hilden, Germany)
under standard conditions. Cycling-conditions on a Bio-
metra T gradient 96-well thermocycler were: 15 min at
95°C, [0.5 min at 95°C, 40 sec at 60°C, 1 min at 72°C]
29×. The fragments were separated on a 2% agarose gel
in TAE-buffer at 150 V for 40 min. The PCR reaction
resulted in fragments of 208 bp and 142 bp in length
for the wt and AS allele, respectively.
Additional material
Additional file 1: BTA23 microsatellite primer sequences. Name and
sequences of up and down primers used to amplify the BTA23
microsatellites used for fine mapping of arachnomelia syndrome.
Additional file 2: Primers for comparative sequencing of candidate
genes. Name, location and sequences of primers used for comparative
sequencing of candidate genes.
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